Hereditary Cancer in Clinical Practice

Papers
(The H4-Index of Hereditary Cancer in Clinical Practice is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
CDKN2A germline alterations and the relevance of genotype-phenotype associations in cancer predisposition35
Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium20
Can harmful lifestyle, obesity and weight changes increase the risk of breast cancer in BRCA 1 and BRCA 2 mutation carriers? A Mini review20
Polymorphisms in MMP-1, MMP-2, MMP-7, MMP-13 and MT2A do not contribute to breast, lung and colon cancer risk in polish population14
Public support for healthcare-mediated disclosure of hereditary cancer risk information: Results from a population-based survey in Sweden13
Cytotoxic and targeted therapy for BRCA1/2-driven cancers12
Genetic susceptibility to hereditary non-medullary thyroid cancer11
Danish guidelines for management of non-APC-associated hereditary polyposis syndromes10
BRCA1 and BRCA2 mutations in ovarian cancer patients from Belarus: update8
Progress of HOTAIR-microRNA in hepatocellular carcinoma8
Population or family history based BRCA gene tests of breast cancer? A systematic review of economic evaluations8
0.025753021240234